Chongqing Huapont Pharm. Co., Ltd.
Chongqing Huapont Pharm. Co., Ltd. (Chongqing Huapont) is a publicly held China-based pharmaceutical company. The company is principally engaged in manufacture and marketing of active pharmaceutical ingredients (APIs). It is engaged in the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology. The company is mainly focused on the research and development of retinoic acids series products, and it also can provide retinoic acid products in China. Chongqing Huapont also engaged in the design, development and optimizing synthetic routes, producing and scaling up intermediates and APIs, process development, process validation and commercial manufacturing. Its product development process include lab chemistry development, analytical methods development and validation. Chongqing Huapont is headquartered at Chongqing, China.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

